Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Braskem (BAK) EBITDA (2016 - 2025)

Braskem has reported EBITDA over the past 16 years, most recently at $358.2 million for Q1 2025.

  • For Q1 2025, EBITDA changed N/A year-over-year to $358.2 million; the TTM value through Mar 2025 reached $1.8 billion, changed N/A, while the annual FY2025 figure was -$335.2 million, 80.52% down from the prior year.
  • EBITDA for Q1 2025 was $358.2 million at Braskem, down from $839.3 million in the prior quarter.
  • Over five years, EBITDA peaked at $839.3 million in Q4 2023 and troughed at $257.0 million in Q3 2023.
  • A 4-year average of $461.4 million and a median of $374.6 million in 2022 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 74.22% in 2021 and later skyrocketed 114.68% in 2023.
  • Year by year, EBITDA stood at $346.7 million in 2021, then increased by 12.77% to $391.0 million in 2022, then soared by 114.68% to $839.3 million in 2023, then tumbled by 57.32% to $358.2 million in 2025.
  • Business Quant data shows EBITDA for BAK at $358.2 million in Q1 2025, $839.3 million in Q4 2023, and $257.0 million in Q3 2023.